Source: Scientific Reports. Unidades: FMRP, ICB
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, LISOSSOMOS, PROTEÍNAS QUINASES, INIBIDORES DE ENZIMAS, MEDICAMENTO, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, Brunno Gilberto Santos et al. Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia. Scientific Reports, v. 14, n. 1, p. 25 , 2024Tradução . . Disponível em: https://doi.org/10.1038/s41598-024-74168-z. Acesso em: 27 nov. 2025.APA
Macedo, B. G. S., Melo, M. A. de, Pereira-Martins, D. A., Traina, F., & Machado Neto, J. A. (2024). Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia. Scientific Reports, 14( 1), 25 . doi:10.1038/s41598-024-74168-zNLM
Macedo BGS, Melo MA de, Pereira-Martins DA, Traina F, Machado Neto JA. Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia [Internet]. Scientific Reports. 2024 ; 14( 1): 25 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41598-024-74168-zVancouver
Macedo BGS, Melo MA de, Pereira-Martins DA, Traina F, Machado Neto JA. Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia [Internet]. Scientific Reports. 2024 ; 14( 1): 25 .[citado 2025 nov. 27 ] Available from: https://doi.org/10.1038/s41598-024-74168-z
